IN UTERO SMALL AND LARGE ANIMAL RESOURCE CORE
- Institution
- CHILDREN'S HOSP OF PHILADELPHIA, PA
- Principal investigator
- Alan W. Flake
- Funding
- $457K
- Duration
- 2023–2028
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Many monogenic diseases strike prior to or soon after birth and cause significant morbidity and mortality. In utero genome editing (IUGE) takes advantage of normal fetal properties, including small size, abundant progenitor cells, and immature immune system, to safely and efficiently institute the genome editing therapeutic prior to the onset of pathology. To fully understand the potential of IUGE and in preparation for IND applications, rigorous small and large animal studies are required to assess efficacy as well as fetal and maternal safety. The In Utero Small and Large Animal Resource Core will provide the knowledge and technical expertise required to design, implement and analyze in vivo gene editing therapies in mouse and large animal fetal models, including nonhuman primates.
LOADING MOONBASE SCORE
Questions for CHILDREN'S HOSP OF PHILADELPHIA
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Children'S Hosp of PhiladelphiaReviewed
Effects of Sleep on Bone Density and Strength in Adolescence: A Prospective Longitudinal Study
Jonathan Andrew Mitchell · $652K · 2020–2026
- NIH · Children'S Hosp of PhiladelphiaNot yet scored
Reducing Disparities in Access to High-level Neonatal Intensive Care and Neonatal Outcomes
Erika M. Edwards · $736K · 2025–2030
- NIH · Children'S Hosp of PhiladelphiaNot yet scored
Mechanistic human studies to prevent Hirschsprung-associated enterocolitis
Robert O Heuckeroth · $723K · 2025–2028